Gaerolwe Masheto, Sean S Brummel, Lauren Ziemba, John Shepherd, Tapiwa Mbengeranwa, Laarni Igawa, Anne Coletti, Dorinda Mukura, Lindie Rossouw, Gerhard Theron, Chelsea Krotje, Patrick Jean-Philippe, Nahida Chakhtoura, Haseena Cassim, Sisinyana Ruth Mathiba, Joel Maena, William Murtaugh, Lee Fairlie, Judith Currier, Risa Hoffman, Lameck Chinula, Paul E Sax, Lynda Stranix-Chibanda, Shahin Lockman
BACKGROUND: Safety data from randomized trials of antiretrovirals in pregnancy are scarce. We evaluated maternal bone and renal data from the International Maternal Pediatric Adolescent AIDS Clinical Trials Network 2010 trial, which compared the safety and efficacy of 3 antiretroviral therapy regimens started in pregnancy: dolutegravir + emtricitabine/tenofovir alafenamide (DTG + FTC/TAF), dolutegravir + emtricitabine/tenofovir disoproxil fumarate (DTG + FTC/TDF), and efavirenz/emtricitabine/tenofovir disoproxil fumarate (EFV/FTC/TDF)...
October 1, 2024: Journal of Acquired Immune Deficiency Syndromes: JAIDS